TODDE SERGIO CAMILLO

Korde, A., Patt, M., Selivanova, S., Scott, A., Hesselmann, R., Kiss, O., et al. (2024). Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework. EJNMMI RADIOPHARMACY AND CHEMISTRY, 9(1) [10.1186/s41181-023-00230-2]. Detail

Boschi, S., Todde, S. (2023). Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 50, 2921-2924 [10.1007/s00259-023-06244-x]. Detail

Rainone, P., Valtorta, S., Villa, C., Todde, S., Cadamuro, M., Bertoli, G., et al. (2023). Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(18) [10.3390/ijms241814124]. Detail

Boschi, S., Todde, S. (2022). PET radiopharmacy and automation. In Nuclear Medicine and Molecular Imaging - Vol. 1 (pp. 227-234). Elsevier [10.1016/B978-0-12-822960-6.00004-1]. Detail

Gillings, N., Hjelstuen, O., Behe, M., Decristoforo, C., Elsinga, P., Ferrari, V., et al. (2022). EANM guideline on quality risk management for radiopharmaceuticals. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 49(10), 3353-3364 [10.1007/s00259-022-05738-4]. Detail